Pages

Monday, August 4, 2014

Final patient treated in ALS stem cell procedure

Neuralstem, Inc. announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis .

http://ift.tt/1uff3DS

No comments:

Post a Comment